Roche focuses on diagnostics to help cut healthcare costs
It can enable patients to avoid unnecessary treatment in hospitals and reduce duration of their stay there
Singapore
GIVEN the sweeping trend in Asia - the growing middle class, a rapidly ageing population and an explosion of lifestyle diseases - Roche Diagnostics has pumped money into expanding its diagnostics value chain to help change medical practice and improve quality of care.
Managing director of Roche Diagnostics Asia-Pacific Lance Little told The Business Times that while diagnostics influences over 60 per cent of decisions made by doctors on treatments of diseases and disorders, and that it is essential when it comes to formulating medical guidelines, it receives only 2 per cent of healthcare funding worldwide.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Holiday Inn owner IHG’s Q1 revenue up 2.6%, leisure travel demand remains strong
WSJ moves Asia headquarters from Hong Kong to Singapore
South Korea to slap fines on food suppliers for ‘shrinkflation’
Olam outbids Dreyfus’ sweetened deal for Australia’s Namoi, raises offer to A$0.66 per share
Live Nation’s revenue beats estimates as boom in concerts drive ticket sales
Jim Beam owner bets on canned vodka cocktails to double revenue